Showing results (171-180 of 1,275) with videos related to

Sort By:
Pageof 128
Clinical Lymphoma, Myeloma & Leukemia|June 11, 2011
Fluorodeoxyglucose-positron-emission tomography findings in mantle cell lymphomaAbass Alavi, Sankaran Shrikanthan, Aysel Aydin, et al.
Medical Physics|February 10, 2011
Automatic anatomy recognition via multiobject oriented active shape modelsXinjian Chen, Jayaram K Udupa, Abass Alavi, et al.
AJR. American Journal of Roentgenology|August 24, 2007
Competitive speed eating: truth and consequencesMarc S Levine, Geoffrey Spencer, Abass Alavi, et al.
Clinical Nuclear Medicine|September 17, 2005
Intense esophageal FDG activity caused by Candida infection obscured the concurrent primary esophageal cancer on PET imagingSankaran Shrikanthan, Aysel Aydin, Thiruvenkatasamy Dhurairaj, et al.
Molecular Imaging and Biology|July 5, 2007
Etiopathologies associated with intercostal muscle hypermetabolism and prominent right ventricle visualization on 2-deoxy-2[F-18]fluoro-D-glucose-positron emission tomography: significance of an incidental finding and in the setting of a known pulmonary diseaseSandip Basu, Saad Alzeair, Geming Li, et al.
CA: a Cancer Journal for Clinicians|July 13, 2007
Functional imaging of cancer with emphasis on molecular techniquesDrew A Torigian, Steve S Huang, Mohamed Houseni, et al.
Computer Vision and Image Understanding : CVIU|April 16, 2013
GC-ASM: Synergistic Integration of Graph-Cut and Active Shape Model Strategies for Medical Image SegmentationXinjian Chen, Jayaram K Udupa, Abass Alavi, et al.
Nuclear Medicine Communications|July 16, 2014
Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findingsNeil Masangkay, Sandip Basu, Mateen Moghbel, et al.
Clinical Nuclear Medicine|June 24, 2003
A metabolic imaging severity rating scale for the assessment of cognitive impairmentAndrew Newberg, Adolfo Cotter, Michelle Udeshi, et al.
Clinical Nuclear Medicine|January 6, 2023
Normalization of Liver Physiological Uptake as a Response Marker to Treatment in Prostate Cancer Liver Metastases Appearing as Photopenic on Baseline 18F-Fluorocholine PET/CTJulie Faudemer, Emeline Meriaux, Xavier Tillou, et al.
Pageof 128